A McMaster University team is collaborating in a major nationwide study on the effectiveness of COVID-19 vaccines in people with immune-mediated inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease and psoriasis.
The researchers are examining the immune response to COVID-19 vaccination in 2,500 immune-mediated inflammatory diseases (IMID) patients recruited from British Columbia, Alberta, Manitoba, Ontario, Quebec and Newfoundland….
